| Natalie Mccall, | |
|
118 N Hospital Dr, Abbeville, LA 70510-4039 | |
| (337) 898-6419 | |
| Not Available |
| Full Name | Natalie Mccall |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 118 N Hospital Dr, Abbeville, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073196572 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 218821 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Iberia Medical Center | New iberia, LA | Hospital |
| Franklin Foundation Hospital | Franklin, LA | Hospital |
| Acadia General Hospital | Crowley, LA | Hospital |
| Lafayette General Medical Center | Lafayette, LA | Hospital |
| Our Lady Of Lourdes Regional Medical Center, Inc | Lafayette, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lafayette Health Ventures Inc | 9335043074 | 216 |
News Archive
Ekahau Inc., the performance leader in Wi-Fi-based Real Time Location Systems (RTLS), today announced that Southeast Alabama Medical Center (SAMC), a 370-bed regional hospital in Dothan, Ala., is upgrading its Ekahau RTLS to include campuswide monitoring of its refrigerators and freezers.
The U.S. Department of Health and Human Services (HHS) today awarded $27 million to support pregnant and parenting teens and women in states and tribes across the country. Of the funds, $24 million was awarded to 17 states and tribes through the Pregnancy Assistance Fund, created by the Affordable Care Act.
The introduction of standardized packaging for cigarettes in the UK, combined with stricter taxation measures on cheaper cigarettes, has led to a significant fall in sales for cigarettes, according to a new analysis from researchers at the University of Bath.
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
A ground-breaking paper published simultaneously in two leading international heart journals [20 February 2017] casts fresh light on the current debate relating to the accuracy and cost-efficiency of the ECG as a screening tool to identify athletes with potential life threatening heart conditions – also showing promise for the future of a screening programme for all young people across the UK.
› Verified 2 days ago
| Entity Name | Lafayette Health Ventures Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417986092 PECOS PAC ID: 9335043074 Enrollment ID: O20041105000263 |
News Archive
Ekahau Inc., the performance leader in Wi-Fi-based Real Time Location Systems (RTLS), today announced that Southeast Alabama Medical Center (SAMC), a 370-bed regional hospital in Dothan, Ala., is upgrading its Ekahau RTLS to include campuswide monitoring of its refrigerators and freezers.
The U.S. Department of Health and Human Services (HHS) today awarded $27 million to support pregnant and parenting teens and women in states and tribes across the country. Of the funds, $24 million was awarded to 17 states and tribes through the Pregnancy Assistance Fund, created by the Affordable Care Act.
The introduction of standardized packaging for cigarettes in the UK, combined with stricter taxation measures on cheaper cigarettes, has led to a significant fall in sales for cigarettes, according to a new analysis from researchers at the University of Bath.
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
A ground-breaking paper published simultaneously in two leading international heart journals [20 February 2017] casts fresh light on the current debate relating to the accuracy and cost-efficiency of the ECG as a screening tool to identify athletes with potential life threatening heart conditions – also showing promise for the future of a screening programme for all young people across the UK.
› Verified 2 days ago
| Entity Name | Lafayette General Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649408832 PECOS PAC ID: 4688581457 Enrollment ID: O20100301000064 |
News Archive
Ekahau Inc., the performance leader in Wi-Fi-based Real Time Location Systems (RTLS), today announced that Southeast Alabama Medical Center (SAMC), a 370-bed regional hospital in Dothan, Ala., is upgrading its Ekahau RTLS to include campuswide monitoring of its refrigerators and freezers.
The U.S. Department of Health and Human Services (HHS) today awarded $27 million to support pregnant and parenting teens and women in states and tribes across the country. Of the funds, $24 million was awarded to 17 states and tribes through the Pregnancy Assistance Fund, created by the Affordable Care Act.
The introduction of standardized packaging for cigarettes in the UK, combined with stricter taxation measures on cheaper cigarettes, has led to a significant fall in sales for cigarettes, according to a new analysis from researchers at the University of Bath.
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
A ground-breaking paper published simultaneously in two leading international heart journals [20 February 2017] casts fresh light on the current debate relating to the accuracy and cost-efficiency of the ECG as a screening tool to identify athletes with potential life threatening heart conditions – also showing promise for the future of a screening programme for all young people across the UK.
› Verified 2 days ago
| Entity Name | University Hospital & Clinics, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639518087 PECOS PAC ID: 7113161977 Enrollment ID: O20130917000335 |
News Archive
Ekahau Inc., the performance leader in Wi-Fi-based Real Time Location Systems (RTLS), today announced that Southeast Alabama Medical Center (SAMC), a 370-bed regional hospital in Dothan, Ala., is upgrading its Ekahau RTLS to include campuswide monitoring of its refrigerators and freezers.
The U.S. Department of Health and Human Services (HHS) today awarded $27 million to support pregnant and parenting teens and women in states and tribes across the country. Of the funds, $24 million was awarded to 17 states and tribes through the Pregnancy Assistance Fund, created by the Affordable Care Act.
The introduction of standardized packaging for cigarettes in the UK, combined with stricter taxation measures on cheaper cigarettes, has led to a significant fall in sales for cigarettes, according to a new analysis from researchers at the University of Bath.
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
A ground-breaking paper published simultaneously in two leading international heart journals [20 February 2017] casts fresh light on the current debate relating to the accuracy and cost-efficiency of the ECG as a screening tool to identify athletes with potential life threatening heart conditions – also showing promise for the future of a screening programme for all young people across the UK.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalie Mccall, 851 Highway 93 N, Scott, LA 70583-4418 Ph: (337) 962-7985 | Natalie Mccall, 118 N Hospital Dr, Abbeville, LA 70510-4039 Ph: (337) 898-6419 |
News Archive
Ekahau Inc., the performance leader in Wi-Fi-based Real Time Location Systems (RTLS), today announced that Southeast Alabama Medical Center (SAMC), a 370-bed regional hospital in Dothan, Ala., is upgrading its Ekahau RTLS to include campuswide monitoring of its refrigerators and freezers.
The U.S. Department of Health and Human Services (HHS) today awarded $27 million to support pregnant and parenting teens and women in states and tribes across the country. Of the funds, $24 million was awarded to 17 states and tribes through the Pregnancy Assistance Fund, created by the Affordable Care Act.
The introduction of standardized packaging for cigarettes in the UK, combined with stricter taxation measures on cheaper cigarettes, has led to a significant fall in sales for cigarettes, according to a new analysis from researchers at the University of Bath.
Genmab A/S announced today an agreement to create and develop human antibody therapeutics for disorders of the central nervous system (CNS) with H. Lundbeck A/S. Genmab will create novel human antibodies to three targets identified by Lundbeck. Lundbeck will have access to Genmab's antibody creation and development capabilities, including its state of the art, fully automated pre-clinical antibody screening and characterization capabilities and its proprietary stabilized IgG4 and UniBody therapeutic antibody platforms.
A ground-breaking paper published simultaneously in two leading international heart journals [20 February 2017] casts fresh light on the current debate relating to the accuracy and cost-efficiency of the ECG as a screening tool to identify athletes with potential life threatening heart conditions – also showing promise for the future of a screening programme for all young people across the UK.
› Verified 2 days ago
Mrs. Teddi Poche' Willis, APRN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2305 Richard St, Abbeville, LA 70510 Phone: 337-892-9800 | |
Diana Locsin Verdeflor, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1009 Charity St, Abbeville, LA 70510 Phone: 337-893-3443 | |
Mary Ricaud Leblanc, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2615 North Dr, Abbeville, LA 70510 Phone: 337-893-1506 | |
Mrs. Crystal Hancox, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2419 Alonzo St, Abbeville, LA 70510 Phone: 337-892-0630 | |
Haley Miller, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 121 E Saint Victor St, Abbeville, LA 70510 Phone: 337-893-0810 | |
Torie Tauzin, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2421 Alonzo St, Abbeville, LA 70510 Phone: 337-892-6919 |